Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

IGC Pharma (IGC) Times Interest Earned (2016 - 2017)

IGC Pharma (IGC) has disclosed Times Interest Earned for 8 consecutive years, with -$7.81 as the latest value for Q4 2017.

  • Quarterly Times Interest Earned rose 5.96% to -$7.81 in Q4 2017 from the year-ago period, while the trailing twelve-month figure was -$3.09 through Sep 2018, up 62.02% year-over-year, with the annual reading at -$9.19 for FY2017, 32.32% up from the prior year.
  • Times Interest Earned for Q4 2017 was -$7.81 at IGC Pharma, down from -$6.44 in the prior quarter.
  • The five-year high for Times Interest Earned was $9.87 in Q1 2015, with the low at -$52.04 in Q1 2016.
  • Average Times Interest Earned over 5 years is -$8.84, with a median of -$7.45 recorded in 2015.
  • The sharpest move saw Times Interest Earned crashed 1226.5% in 2013, then surged 1299.32% in 2015.
  • Over 5 years, Times Interest Earned stood at -$5.6 in 2013, then plummeted by 43.86% to -$8.06 in 2014, then increased by 8.73% to -$7.35 in 2015, then dropped by 13.01% to -$8.31 in 2016, then grew by 5.96% to -$7.81 in 2017.
  • According to Business Quant data, Times Interest Earned over the past three periods came in at -$7.81, -$6.44, and -$8.9 for Q4 2017, Q3 2017, and Q2 2017 respectively.